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A SINGLE AMINO ACID SUBSTITUTION IN THE a3
DOMAIN OF AN H-2 CLASS I MOLECULE ABROGATES
REACTIVITY WITH CTL
BY TERRY A. POTTER,* JEFFREY A. BLUESTONE,' AND T. V. RAJAN*4
From the Departments of*Pathology, and *Microbiology and Immunology, Albert Einstein
College ofMedicine, New York 10461; and the ITransplantation Biology Section, Immunology
Branch, National Cancer Institute, National Institutes ofHealth, Bethesda, Maryland 20205
Surface molecules encoded by the MHC provide the context for antigen
recognition by T lymphocytes (1) . The molecular cloning of the genes, as well
as genes for the T cell receptor, has provided a means for studying the relation-
ship between T cell function and the specificity for MHC class I or class II
molecules . The molecular mapping of determinants on H-2 class I molecules
that are recognized by alloreactive cytotoxic T lymphocytes (CTL) was accom-
plished by the analysis of hybrid H-2 class I molecules constructed by exon
shuffling in vitro . Such studies showed that the reactivity of CTL specific for H-
2 class I molecules was directed at determinants in the al and a2 domains (2-
4) . A similar finding was obtained with CTL directed against chemically modified
H-2 class I molecules, as well as H-2 class I-restricted antiviral CTL responses
(5-7) .
Previously, we isolated by immunoselection a somatic cell mutant that ex-
pressed a Dd molecule that failed to express a serologic determinant (34.2.12)
that had been mapped to the a3 domain, while retaining all of the serologically
defined al and a2 determinants (8) . In contrast to what had been predicted
from the exon-shuffling experiments, cells expressing this mutant Dd molecule
were not killed by anti-W-reactive CTL. It remained possible that, in addition
to the change in the a3 domain that resulted in the loss of 34.2.12 binding, there
were changes in the al or a2 domain of the variant H-2Dd molecule, and that
the al/a2 changes were responsible for the loss of CTL reactivity . We have now
determined that exon 4 of the mutant Dd gene has undergone a single mutation
resulting in a glutamic acid to lysine substitution at residue 227 in the a3 domain .
Using oligonucleotide-directed mutagenesis, we have reproduced this mutation
in the cloned H-2Dd gene. Cells transfected with this gene are not recognized by
alloreactive anti-Dd CTL. Our studies therefore raise the possibility that, though
not identified in the exon-shuffling experiments, residues in the a3 domain of
H-2 class I molecules contribute to determinants recognized by CTL.
This work was supported by grants CA-29194, CA-13330, and AI-10702 from the National Institutes
of Health; grant PCM 8400114 from the National Science Foundation ; and grant CD 293 from the
American Cancer Society .
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Materials and Methods
Mice . All strains of mice used in this study were either bred in our own colony (NIH,
Bethesda, MD) or purchased from The Jackson Laboratory (Bar Harbor, ME) .
Cell Lines. The Dd somatic cell variant ACCb 34.2.12-4 H-26- has been described
previously (8) . In brief, it was isolated by immunoselection (9) using the anti-D' mAb
34.2.12 and rabbit complement, after pretreating the parental cell line ACCb (H-2d X H-
2b)F, with the chemical mutagen ethylmethane sulfonate.
The other cell line into which the Dd genes were transfected, R8.69.9.15 (referred to
herein as R8.15), was isolated from R8 (H-2d X H-2b)F, by immunoselection (10). The
R8.15 cell line does not possess H-2'-encoded genes . The T cell hybridoma, 3DT.52.5.8
was a kind gift from Dr . P . Marrack, and is described elsewhere (11, 12) .
Sequencing ofDd mRNA from the Parental and Mutant Cell Lines. The sequence of the
a3 domain of the H-2D' molecules was determined by sequencing uncloned mRNA using
the procedure of Geliebter et al . (13) . In brief, RNA was extracted from 2 X 109 cells
using the guanidinium isothiocyanate method (14) and the poly(A)+ fraction was isolated
by passage through oligo(dT) cellulose (15) . An oligonucleotide complementary to and
specific for mRNA at residues 287-281 (16) was labelled with "P using T4 polynucleotide
kinase, and 5 ng was annealed to 10 ug of the poly(A)+ RNA at 50°C . The primer was
extended using avian myeloblastosis virus reverse transcriptase (Life Sciences Inc ., St .
Petersburg, FL) at 50°C for 45 min . Electrophoresis of the samples was performed in 8%
acrylamide sequencing gels .
Northern Blots. 30 Ag oftotal RNA was electrophoresed in a 1 % agarose gel containing
formaldehyde (1%) in borate buffer . The separated RNA was transferred to Gene Screen
(New England Nuclear, Boston, MA) paper and hybridized in 5X SSC/IOX Denhardt's
solution/10% dextran sulfate/7% SDS overnight, at 5 °C below the denaturation temper-
ature of the oligonucleotide, as previously described (17) . The blots were washed at the
hybridizing temperature for 1 h in 3X SSC/10% Denhardt's solution/5% SDS, and then
1 h in 1X SSC/ 1% SDS .
Oligonucleotide-directed Mutagenesis of the Dd Gene. The Dd gene, present as an 8 kb
Eco RI fragment in pBR327 was kindly provided by Dr . David Margulies (NIH) . The
1,996 by Hpa I fragment containing exons 4-8 of Dd was ligated to Kpn 1 linkers (New
England Biolabs, Beverly, MA) and cloned into M13mpl9. Mutagenesis was performed
using the oligonucleotide-directed in vitro mutagenesis system from Amersham Corp .
(Arlington Heights, IL) . This procedure produces a higher frequency of plaques with the
mutant sequence, as it exploits the observation that a strand that incorporates thiolated
nucleotides is not nicked by restriction enzymes such as Nci I (18) . Thus, after the template
strand is nicked with Nci 1, it is partially digested with exonuclease III and then
resynthesized with DNA polymerase I to form a mutant homoduplex . In separate reac-
tions, two oligonucleotides were used : one with the wild-type sequence and the other the
mutant sequence containing the mismatched basepair in the middle . The DNA was
transformed into Escherichia coli K12 TGI (TG 1) rendered transformation competent
with CaCl2 (19) .
Eight plaques arising from the mutagenesis with both the mutant and the wild oligo-
nucleotides were grown up and spotted onto Gene Screen paper and probed with the
oligonucleotide used for priming under the same conditions as described above for the
Northern blots . In both cases, the priming oligonucleotide hybridized with seven of the
eight plaques . Single-stranded phage DNA was prepared, and the sequence was confirmed
by DNA sequencing using standard M 13 dideoxynucleotide sequencing . Double-stranded
DNA from one of these phages was isolated by alkaline lysis from 50 ml of TG1 that had
been infected at ODsoo 1 .0 with 10'° PFU/ml of phage and grown for 2 h at 37°C . The
2 kb Kpn 1 fragment was ligated into the unique Kpn 1 site in the pSV2-neo plasmid
containing the rest of the Dd gene (see Fig . 3) . The correct orientation was identified by
restriction mapping with Xmn 1 .
Transfection ofthe Wild Type andMutant Dd Genes. The wild type and mutant Dd genes
that had been cloned into pSV2neo were transfected into R8.15 by electroporation as
described by Potter et al . (20) using 10' cells and 100 ug of uncut plasmid DNA. 48 h
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after electroporation, G-418 sulfate antibiotic (Gibco, Grand Island, NY) was added to a
final concentration of 1 .0 mg/ml. Clones appeared 14-20 d later and were assayed for
expression of H-2Dd by microcytotoxicity using the al/a2 Dd-specific mAb 34 .4.21 .
Flow Microfuorometric Analysis of H-2 Antigen Expression . For immunofluorescence
staining, 106 cells in 100 ul of DME/FCS were incubated for 30 min on ice with an
optimal amount (10 tul) of anti-H-21)d mAb . The cells were then washed and incubated
on ice for a further 30 min with FITC-conjugated goat anti-mouse immunoglobulin .
After staining, the cells were washed, and the fluorescence of 20,000 viable cells was
measured on a FACS II (Becton Dickinson Immunocytometry Systems, Mountain View,
CA).
Generation of Specific CTL Populations . Allogeneic effector cells were generated by in
a 5-d primary culture of C57BL/10 spleen cells as previously described (21, 22) . In brief,
5 X 10' splenic responder cells or 2 X 106 purified T cells were mixed with 4 X 106
irradiated (3,300 rad) stimulator cells in a final volume of 2 ml of culture media . An
exogenous source of IL-2 (lectin-free Con A-induced supernatant) was added to some
cultures to a final concentration of 10% . The cultures were incubated for 5-6 d at 37°C
in 10% C02-
Measurement ofCTL Reactivity by "CrRelease. Target cells were radiolabelled with "Cr
by incubating 2-4 X 10 6 cells in 300 jiCi of Na"Cr03 in 0.3 ml FCS for 1 h . Radiolabelled
cells were then washed three times and resuspended at 5 X 104 cells/ml . Effector cells
were harvested and resuspended at 5 X 106 cells/ml . Effector cells and target cells (100
jul) were incubated together in 96-well U-bottom plates (Costar, Cambridge, MA) for 4-
5 h at 37 ° C . Culture supernatants were harvested using the Titertek Supernatant
Collection System (Skatron Inc ., Sterling, VA) . Specific lysis was determined as : percent
specific release = 100 X [(experimental release) - (spontaneous release)]/[(maximum
release) - (spontaneous release)] . The experimental lysis represents the release of "Cr
from target cells incubated with effector cells . The spontaneous lysis is given by the release
of "Cr from target cells in the absence of effector cells . The maximum release is given
by the release of 'Cr released by target cells in the presence of 0 .05 N HCI .
Measurement ofStimulation ofthe IL-2-secreting Hybridoma. The ability ofthe transfected
cells to stimulate IL-2 production by the T cell hybridoma 3DT.52.5.8 was assayed as
described by Greenstein et al ., (23) . In brief, 10 5 3DT.52.5.8 cells were cultured with 105
irradiated stimulator cells in a total volume of 1 ml for 24 h at 37°C . The supernatant
was harvested and aliquots were assayed for their ability to support the growth of the IL-
2-dependent cell line CTLL-1, by measuring the incorporation of [ 5H]thymidine during
a 6-h pulse with 2 ACi/well [ 6H]thymidine .
Results
Identification ofthe Mutation in the Somatic Cell Variant. The sequence of the
a3 domain of the Dd molecule in the ACCb 34.2 .12-4 H-26 cell line was
determined by sequencing of the H-2Dd mRNA using an oligonucleotide that
hybridized to H-2Dd mRNA in the transmembrane region . The sequence of the
entire 0 domain was determined and compared with the published nucleotide
sequence of H-2Dd (24), as well as the sequence determined for the a3 domain
ofthe H-2Dd molecule of the parental cell line . There was only a single nucleotide
difference, a G to A transition near the middle of the domain that resulted in a
substitution of lysine in the mutant molecule for the wild-type glutamic acid at
residue 227 (Fig . 1) . The identification of an acid to base substitution is consistent
with the observation that the mutant Dd molecule has a more basic isoelectric
point (8) . It is noteworthy that in all the H-2 class I sequences determined,
residue 227 is an aspartic acid, whereas it is glutamic acid in H-2Dd . Therefore,
it is most likely that this residue composes part of the determinant recognized by
the H-2Dd-specific mAb 34.2 .12 .
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224 225 226 227 228 229 230 FIGURE 1. Part ofthe nucleotide sequence of
the wild-type (from ACCb H-26- ) and the mu-
ACCb H-2b-	CTG ACC CAG GAA ATG GAG CTT tant (from ACCb 34.2.12' H-2''-) Dd gene as
Leu Thr Gtn Gtu Met Gtu Leu determined by RNAsequencing. The sequence
ofthe entire a3 domain ofthe Dd mRNA from
both cell lines was determined, and the only
ACCb 34 .2 .12-4 H-2b - . . . . . . . . . A. . . . . . . . . . . difference with that of the published H-2D'
tys sequence (24) was at residue 227, as shown.
FIGURE 2. Northern blot of wild-type
and mutant Dd RNA. RNA was isolated
from the ACCb H-2b- (lanes 1, 3, and 5)
and mutant ACCb 34.2 .12' H-2b- (lanes
2, 4, and 6) cell lines and after electro-
phoresis and transfer to a Gene Screen
filter, probed with oligonucleotides. The
sequences of all three oligonucleotides
were complementary to that of H-2Dd
mRNA . Lanes 1 and 2, an oligonucleo-
tide to residues 287-281; Lanes 3 and
4, an oligonucleotide to the wild-type Dd
sequence from residues 230-224, and
lanes 5 and 6, an oligonucleotide to the
mutant Dd sequence from residues 230-
224.
The sequence alteration determined for the mutant Dd molecule was con-
firmed by Northern blot analysis using oligonucleotides specific for the parental
and mutant sequences . As can be seen in Fig. 2, RNA from both the parental
and mutant cell lines hybridized with the oligonucleotide to the H-2Dd trans-
membrane region that was used as a primer for the RNA sequencing (Fig . 2,
lanes 1 and 2). The oligonucleotide specific for the wild-type H-2Dd sequence
from residues 224-230 hybridized with RNA from the parental cell line but not
with RNA from the mutant cell line (Fig . 2, lanes 3 and 4) . Similarly, the
oligonucleotide specific for the mutant sequence in this region hybridized with
RNA from the mutant cell line but not RNA from the parental cell line (Fig . 2,
lanes 5 and 6) . The results of these Northern blots therefore confirm the
existence of the mutation identified in the RNA sequencing of the mutant Dd
molecule .
Having identified the nature of the mutation in ACCb 34.2 .12-a H-2b- , we
reproduced this change and examined its effect in the cloned H-2Dd gene . The
H-2Dd gene cloned in pBR327 was obtained from Dr. D. Margulies, and
mutagenesis was performed as described in the Materials and Methods as well as
Fig. 3. The cell line R8 .15 was chosen as the recipient cell for the reconstructed
genes for the following technical reasons: (a) it is readily transfectable by
electroporation ; (b) it is a good target for measuring specific CTL reactivity and;
(c) it does not possess any H-2d-encoded genes (10) .
Clones that were resistant to G418 were examined for expression of H-2Dd by
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FIGURE 3. Scheme for oligonucle-
otide-directed mutagenesis of the
fourth exon of H-2Dd. The H-2Dd
gene, cloned as an 8 kb Eco RI frag-
ment in pBR327, was obtained from
Dr . David Margulies. Plasmid DNA
was cut with Hpa 1 . Kpn I linkers
were ligated and the fragment con-
taining exons 4-8 was cloned into
M13mp19 . Oligonucleotide-directed
mutagenesis was performed as de-
scribed in the Materials and Methods.
The fragment containing exons 1-3
of Dd was cloned in pBR327 by the
addition of Kpn I linkers at the Hpa
I site at the 3' end of the gene and
religating with the unique Kpn I site
in the third intron . This 4.2 kb Eco RI fragment was then cloned into the unique Eco RI site of
pSV2-neo . To reconstruct the gene after mutagenesis, double-stranded RF DNA containing exons
4-8 was isolated, digested with DNA, and cloned into the unique Kpn I site in the pSV2-neo plasmid
containing H-2D' exons 1-3. Note that although a 700 by Kpn I-Hpa I fragment in intron 3 is lost
in this manipulation, it was not necessary for expression of H-2Dd. The black boxes denote the H-
2Dd exons. Restriction enzyme sites : R, Eco RI ; K, Kpn I; Hp, Hpa I.
microcytotoxicity. Three cloned cell lines were selected for study: (a) R8.15, the
G418-sensitive cell line without any transfected genes; (b) R8.15 Dd Glu, a G418-
resistant clone that was transfected with pSV2-neo containing the H-2Dd gene
with glutamic acid at residue 227 (wild-type Dd) ; (c) R8.15 Dd Lys, a G418-
resistant clone that was transfected with pSV2-neo containing the H-2Dd gene
with lysine at residue 227 (mutant Dd) . The expression of the H-2Dd molecule
on these three cell lines was further analyzed by flow microfluorometry on the
FACS. As shown in Fig. 4, the anti-Dd mAbs 34.2.12 and 34.5 .8 did not react
with R8.15, but did react with R8.15 Dd Glu. The R8.15 Dd Lys cell line reacted
with the 34.5 .8 but not the 34.2 .12 antibody and therefore expressed the same
serological change as the somatic cell mutant ACCb 34.2 .12-4 H-2b- .
Reactivity of Anti-Dd CTL for the Transfected Cells. Having established that
R8.15 Dd Lys showed the same loss of a serologic determinant as the original
somatic cell variant, we examined whether it would serve as a target for anti-Dd
CTL. As shown in Fig. 5, anti-D' CTL generated in a primary in vitro response
lysed the R8.15 Dd Glu but not the R8.15 Dd Lys cells. This finding suggested
that the substitution of Lys at residue 227 of the H-2Dd molecule in R8.15 Dd
Lys reproduced not only the change in serologic determinants, but also the
failure of recognition by anti-Dd-reactive T cells.
Stimulation of IL-2 Production in 3DT.52.5.8 by the Transfected Cells. The T
cell hybridoma 3DT.52.5.8 secretes IL-2 when stimulated by a target cell
expressing H-2Dd. The ability of the three cell lines to elicit IL-2 secretion in
3DT.52.5.8 was determined . It was found that both R8.15 Dd Glu as well as
R8.15 Dd Lys stimulated production of IL-2 by 3DT.52 .5.8 (Table I) . Therefore,
although R8 .15 Dd Lys is not lysed by anti-Dd CTLs, the mutant Dd molecule
still stimulates an anti-H-213d-specific, IL-2-producing T cell hybridoma.
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FIGURE 4. Reactivity of
anti-D' antibodies 34.5 .8 and
34.2.12 with R8.15, and the
transfectants R8.15 Dd Glu
and R8.15 Dd Lys, detected on
the FACS.
FIGURE 5. Reactivity of anti-D' CTL with R8.15 and the Dd transfectants . The target cell
lines were R8 .15 (A); R8.15 Dd Glu (0); and R8.15 Dd Lys (Q) . The effector cells were
C57BL/6 a B10MBR (A) and C57BL/6 a B10.A (5R) (B). Values are given as percent specific
release.
Site-directed mutagenesis and exon shuffling have proved to be useful ap-
proaches to the study of structure-function relationships of H-2 class I molecules
(2-7, 25, 26). The difficulty in using site-directed mutagenesis to define struc-
ture-function relationships for molecules such as H-2 class I that have as many
as 270 extracellular amino acids is deciding what residues to alter and what
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TABLE I
Stimulation ofIL-2 Production by 3DT.52.5.8 in Response to the
Transfected Cell Lines
* Results are expressed as the mean ± SD of six replicate cultures measur-
ing ['H]thymidine incorporation into the IL-2-dependent cell line
CTLL-1 .
residues should be introduced . Exon-shuffling experiments (2-7) have estab-
lished that allele-specific determinants recognized by alloreactive CTL reside in
the a I and a2 domains. In contrast, recent studies on the recognition of a hybrid
MHC class I molecule between the mouse H-2Kb and the human HLA-A2 genes
have demonstrated that replacement of the H-2Kb a3 domain with that of the
HLA-A2 gene can abrogate recognition by some anti-H-2Kb CTL (27 and
Marziarz and Bluestone, manuscript in preparation) . This observation raises the
possibility that the a3 domain may be involved in CTLrecognition. Ourapproach
to the identification of informative structural changes has been to perform
immunoselections with mAbs and characterize the functional and structural
changes. We have been particularly interested in the a3 domain andhave isolated
somatic cell mutants with structural changes in the0 domain of the H-2Ld (28)
or H-2Dd (8) molecule . We found that, for the H-2Ld mutants, there was no
detectable effect on T cell reactivity . In contrast, a somatic cell mutant isolated
by immunoselection using an mAb to the H-2Dd a3 domain was no longer
recognized by anti-Dd-reactive CTL (8).
In this paper we have sequenced mRNA encoding the mutant Dd molecule
and identified a glutamic acid to lysine change at position 227 in the a3 domain .
We have reproduced this mutation in vitro by oligonucleotide-directed mutagen-
esis of a cloned H-2Dd gene and transfected the mutant gene into a H-213d- cell
line . Cells transfected with this mutant gene have the same characteristics as the
original H-2Dd somatic cell mutant . Cells transfected with this gene do not
express the 34.2 .12 determinant nor are they recognized by alloreactive Dd
CTL . As the effector CTL cells used were bulk populations generated in primary
in vitro responses and not single cloned lines, they most probably represented a
polyclonal response, with specificity for several H-2Dd allele-specific determi-
nants.
A trivial explanation for this apparent abrogation of CTL recognition by the
change at residue 227 is that the change in charge destroys the conformation of
the Dd molecule . Arguments against this explanation are: (a) the reactivity of the
mutant Dd molecule with al/a2 antibodies such as 34 .5.8 (Fig . 4) 34.4 .21,
34 .4.20, 15.1 .5, 20.8.6 (data not shown) is indistinguishable from the wild-type
Dd molecule ; (b) the mutant molecule is associated with (i2 microglobulin (data
not shown); (c) the mutant molecule stimulates the 3DT.52 .5.8 hybridoma to
secrete IL-2 . It should also be noted that between the allelic variations of the a3
domains used in the exon-shuffling experiments there are between four to six
Cell line ['H]Thymidine uptake (cpm)*
R8.15 830 ± 96
R8.15 Dd Glu 10,997 ± 402
R8.15 Dd Lys 9,986 ± 752
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differences that involved changes in charged residues, and these apparently have
no effect on recognition by CTL.
Our data would at first seem to be in conflict with the exon-shuffling experi-
ments, which suggested that residues in the a3 domain are not recognized by
CTL. It is possible to reconcile our findings with those of the exon-shuffling
experiments by proposing that the a3 domain expresses a conserved or mono-
morphic determinant(s) recognized by CTL, and that this determinant is de-
stroyed by the glutamic acid to lysine substitution at residue 227. If such a
putative monomorphic or invariant determinant does exist, then replacement of
the a3 domain with the a3 domain of other H-2 class I genes or alleles in the
exon-shuffling experiments would not have revealed its presence . Of the three
external domains, the most likely one to express a conserved determinant would
be the a3 domain, since this region has the greatest level of amino acid homology
among different H-2 class I genes and alleles. In particular, residues 200-250
are identical in the H-2Kk, Db, and Ld genes, H-2Kb shows one substitution, and
H-2K' and H-2Dd each have only two substitutions (24, 29-33) . There exists
much greater allelic variation in the al and a2 domains. It may therefore be
that selective pressure has not only generated variation in the al/a2 domains,
but also conserved an invariant a3 domain .
Evidence for the existence of conserved determinants on MHC class I and
class II molecules has come from blocking experiments using mAbs (34, 35).
These experiments suggest that molecules such as Lyt-2 (for class I) and L3T4
(for class II) molecules (36) provide accessory recognition to that of the T cell
receptor . This is particularly evident in clones with lower affinity (37) . Further-
more, Dembic et al . (38) have recently demonstrated that transfection of the
CD8/Lyt-2 gene enhances cytotoxicity by T cells given the T cell receptor a and
,Q chain genes from a donor CTL line.
Our results establish that residue 227 contributes to a determinant recognized
by most CTL but not by the IL-2-producing hybridoma 3DT.52.5 .8 . The
3DT.52.5.8 hybridoma is L3T4- and Lyt-2- (23), indicating that these molecules
are not involved in the recognition of Dd by the hybridoma. The fact that H-
2Dd stimulates IL-2 secretion in 3DT.52.5.8, even in the absence of accessory
molecules, suggests that the antigen-specific receptor on 3DT.52.5 .8 is of high
affinity . We therefore propose that the anti-D d CTL populations that we assayed
need to recognize a conserved determinant in the a3 domain as well as the allele-
specific determinants in al/a2. In contrast, the 3DT.52.5.8 hybridoma needs to
recognize only the al/a2 allele-specific determinants and not the conserved
determinant in a3 . The noninvolvement of the conserved determinant in rec-
ognition by 3DT.52 .5.8 may be due either to the hybridoma expressing a
receptor of very high affinity for the al/a2 determinants, or alternatively, that
the threshold for IL-2 stimulation may be lower than that required for CTL
lysis . We are currently extending these studies by generating CTL that have
high affinity for their target cell and are not dependent on accessory molecules,
such as Lyt-2, for reactivity . If such high-affinity CTL need only to recognize
al/a2 determinants and not the conserved determinant in a3, we predict that
such CTL should be able to lyse cells such as R8.15 Dd Lys, in which the
conserved determinant has been destroyed .
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Summary
We previously described a somatic cell expressing a variant H-21)d molecule
that did not serve as a target for alloreactive anti-Dd CTL. The mutant cell line
had been isolated by its failure to express a serological epitope present on the H-
2Dd a3 domain . In the present study the a3 domain of the Dd molecule of this
somatic cell variant was sequenced and a single nucleotide change resulting in a
glutamic acid to lysine substitution at residue 227 was identified . This change
was reproduced in the cloned H-2Dd gene by oligonucleotide-directed mutagen-
esis . Cells transfected with this mutant gene were not killed by anti-H-2D d CTL.
Because previous studies using hybrid H-2 class I molecules had established that
the a3 domain does not express allele-specific determinants recognized by CTL,
our results raise the possibility that residues in the a3 domain of H-2 class I
molecules are critical for CTL recognition and constitute a conserved (or
monomorphic) determinant recognized by CTL.
We are most grateful to Dr. D. Margulies for providing the cloned H-2D d gene and to
Dr . P . Marrack for the 3DT.52.5.8 hybridoma cell line . We thank Dr . Nadine Chien for
help with the RNA sequencing technique, Mrs. Edith Palmieri for synthesizing oligonu-
cleotides, and Mrs . Kathy Rapelje and Michele Foo for expert technical assistance with
the FACS and CTL analysis, respectively . We wish to also thank Ms. Rosina Passela for
the preparation of this manuscript .
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